Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Disposition index (DI) and glucose effectiveness (S(G)) are risk factors for diabetes. However, the effect of DI and S(G) on future diabetes has not been examined in large epidemiological studies using direct measures. RESEARCH DESIGN AND METHODS: Insulin sensitivity index (S(I)), acute insulin response (AIR), and S(G) were measured in 826 participants (aged 40-69 years) in the Insulin Resistance Atherosclerosis Study (IRAS) by the frequently sampled intravenous glucose tolerance test. DI was expressed as S(I) x AIR. At the 5-year follow-up examination, 128 individuals (15.5%) had developed diabetes. RESULTS: The area under the receiver operating characteristic curve of a model with S(I) and AIR was similar to that of DI (0.767 vs. 0.774, P = 0.543). In a multivariate logistic regression model that included both DI and S(G), conversion to diabetes was predicted by both S(G) (odds ratio x 1 SD, 0.61 [0.47-0.80]) and DI (0.68 [0.54-0.85]) after adjusting for demographic variables, fasting and 2-h glucose concentrations, family history of diabetes, and measures of obesity. Age, sex, race/ethnicity, glucose tolerance status, obesity, and family history of diabetes did not have a significant modifying impact on the relation of S(G) and DI to incident diabetes. CONCLUSIONS: The predictive power of DI is comparable to that of its components, S(I) and AIR. S(G) and DI independently predict conversion to diabetes similarly across race/ethnic groups, varying states of glucose tolerance, family history of diabetes, and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 2×
“Firstphase insulin secretion compensates for the worsening of insulin sensitivity (2).”
Self-citationMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 2×
“Although reduced in individuals with impaired glucose tolerance (IGT) and diabetes (4,13), SG contributes to glucose tolerance even in conditions of significant insulin resistance, including diabetes (13).”
Self-citationAssessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Self-citationUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492 · cited 2×
“To meet these aims, we used data from the Insulin Resistance Atherosclerosis Study (IRAS), a multicenter observational epidemiological study of different ethnic groups and varying states of glucose tolerance (19).”
Self-citationWELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337 · cited 2×
“0 [1994], Los Angeles, California, courtesy of Richard Bergman, PhD) (21).”
InfluentialSelf-citationEvaluation of proposed oral disposition index measures in relation to the actual disposition index
Retnakaran, R., Qi, Y., Goran, M. I., & Hamilton, J. K. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02841.x · Cited by 320 · cited 1×
“This product has been shown to have a modest correlation with minimal model–derived DI, to decrease as glucose tolerance status deteriorates, and to predict the development of diabetes independent of other risk factors including fasting and 2-h glucose concentrations (7,8).”
Role of Glucose Effectiveness in the Determination of Glucose Tolerance
Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C., & Bergman, R. N. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.1018 · Cited by 290 · cited 1×
“Although reduced in individuals with impaired glucose tolerance (IGT) and diabetes (4,13), SG contributes to glucose tolerance even in conditions of significant insulin resistance, including diabetes (13).”
Self-citationThe Natural Course of β-Cell Function in Nondiabetic and Diabetic Individuals
Festa, A., Williams, K., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1100 · Cited by 271 · cited 1×
“In studies using direct methods, such as the frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis, this relationship is hyperbolic (2) and similar across glucose tolerance categories (3).”
Self-citationBeta cell function and its relation to insulin action in humans: a critical appraisal
Ferrannini, E., & Mari, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1381-z · Cited by 262 · cited 2×
“The hyperbolic paradigm of the minimal model–derived DI has also been criticized (10).”
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S. C., de las Fuentes, L., He, S., Okunade, A. L., Patterson, B. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.005 · Cited by 886
“…during high-dose insulin infusion (stage 2) of the clamp procedure. function is an important risk factor for future development of type 2 diabetes (Lorenzo et al., 2010), and an improvement in b cell function after weight loss induced by Roux-en-Y gastric bypass surgery is an important…”
Scholtens, D. M., Kuang, A., Lowe, L. P., Hamilton, J., Lawrence, J. M., Lebenthal, Y., Brickman, W. J., Clayton, P., Ma, R. C., McCance, D., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2021 · Cited by 310
Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 259
“A 5-year follow-up study showed that the disposition index and glucose effectiveness were independent predictors of incident T2D after adjusting for traditional risk factors [40].”
The incretin system in healthy humans: The role of GIP and GLP-1
Holst, J. J. (2019) · Metabolism · doi:10.1016/j.metabol.2019.04.014 · Cited by 248
Metadata
- Authors
- Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J. G., & Haffner, S. M.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Wake Forest University Health Sciences (US)
- University of Colorado Health (US)
- Kaiser Permanente (US)
- University of Southern California (US)
- Mount Sinai Hospital (CA)
- Baylor College of Medicine (US)
- Corresponding author
- Lorenzo, Carlos
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-09-01
- Volume
- 33
- Issue
- 9
- Pages
- 2098-2103
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2928371
- OpenAlex
- W2023961601
- Cited by
- 145
- References
- 25
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 14 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 8 · 2014: 16 · 2013: 5 · 2012: 5
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5u01hl047890-09, 5u01hl047887-09, 5u01hl047889-09)
- National Heart, Lung, and Blood Institute (U01HL047902, HL-47889, HL‐47890, HL47887, U01HL047892, HL 47892)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027619, R01DK081796, R01DK029867)
- National Center for Research Resources (M01RR01346, M01RR001346, M01-RR431)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- disposition index, glucose effectiveness, insulin sensitivity, acute insulin response, type 2 diabetes, diabetes risk prediction, insulin resistance, insulin sensitivity index, new-onset diabetes, glucose tolerance, obesity, family history of diabetes
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Risk Factors, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.